HIV-associated disseminated cryptococcosis-An unusual clinical and diagnostic picture with successful cure by single dose liposomal amphotericin B treatment

Copyright © 2024 Elsevier Inc. All rights reserved..

BACKGROUND: Cryptococcosis is an invasive, opportunistic fungal infection seen especially in human immunodeficiency virus (HIV) infected patients. Cryptococcal meningitis (CM) is the second leading cause of mortality in HIV patients. We report a case of disseminated cryptococcosis presenting with altered mental status in a newly diagnosed HIV infection.

METHODS AND RESULTS: A 50-year-old with a short history of altered mental sensorium and a history of low-grade fever and weight loss for few months presented at a tertiary care hospital in North India. He was detected positive for HIV-1. Cryptococcal antigen (CRAG) was positive in Cerebrospinal fluid (CSF), and negative in serum. The fungal culture in CSF was sterile while the fungal blood culture grew Cryptococcus neoformans. The patient was treated with single high-dose Liposomal Amphotericin B (LAmB) therapy followed by Fluconazole and Flucytosine for the next two weeks followed by fluconazole daily for consolidation and maintenance therapy. Antiretroviral therapy (ART) was started 4 weeks after induction therapy. After 6 months, the patient is doing fine.

CONCLUSION: Single dose LAmB along with the backbone of fluconazole and flucytosine appears promising in disseminated cryptococcal infection in HIV-infected individuals.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:109

Enthalten in:

Diagnostic microbiology and infectious disease - 109(2024), 2 vom: 25. Feb., Seite 116217

Sprache:

Englisch

Beteiligte Personen:

Gupta, Chhavi [VerfasserIn]
Dogra, Prerna [VerfasserIn]
Jain, Varun [VerfasserIn]
Kaur, Ravneet [VerfasserIn]
Sharma, Jyoti Bala [VerfasserIn]

Links:

Volltext

Themen:

Case Reports
Cryptococcal antigen (CRAG)
Cryptococcosis
Human immunodeficiency virus (HIV)
Liposomal amphotericin B

Anmerkungen:

Date Revised 21.03.2024

published: Print-Electronic

Citation Status Publisher

doi:

10.1016/j.diagmicrobio.2024.116217

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370031318